97 related articles for article (PubMed ID: 3010581)
1. Alteration of platelet glucose transport system in atherosclerosis.
Yardimci T; Ulutin ON
Wien Klin Wochenschr; 1986 Apr; 98(7):221-4. PubMed ID: 3010581
[TBL] [Abstract][Full Text] [Related]
2. Platelets and diabetic vascular disease.
Paton RC; Passa P
Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
[TBL] [Abstract][Full Text] [Related]
3. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
Artery; 1980; 8(1):73-9. PubMed ID: 6158934
[TBL] [Abstract][Full Text] [Related]
4. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
Fuller JH
Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
[No Abstract] [Full Text] [Related]
5. Kinetics and in vivo distribution of in-111-labelled platelets and platelet function in familial hypercholesterolaemia.
Wessels P; Heyns AD; Esterhuysen AJ; Badenhorst PN; Lötter MG; Pieters H; Kotzè HF
Thromb Haemost; 1987 Oct; 58(3):811-6. PubMed ID: 3433247
[TBL] [Abstract][Full Text] [Related]
6. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
[TBL] [Abstract][Full Text] [Related]
7. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.
Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416
[TBL] [Abstract][Full Text] [Related]
9. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
10. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis.
Tschoepe D; Roesen P; Schwippert B; Gries FA
Semin Thromb Hemost; 1993; 19(2):122-8. PubMed ID: 8356457
[TBL] [Abstract][Full Text] [Related]
11. Increased platelet aggregation in diabetic patients with microangiopathy despite good glycemic control.
Kajita K; Ishizuka T; Miura A; Kanoh Y; Ishizawa M; Kimura M; Yasuda K
Platelets; 2001 Sep; 12(6):343-51. PubMed ID: 11672473
[TBL] [Abstract][Full Text] [Related]
12. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
[TBL] [Abstract][Full Text] [Related]
13. Platelet inhibition by insulin is absent in type 2 diabetes mellitus.
Ferreira IA; Mocking AI; Feijge MA; Gorter G; van Haeften TW; Heemskerk JW; Akkerman JW
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):417-22. PubMed ID: 16339499
[TBL] [Abstract][Full Text] [Related]
14. [Significance of thrombocytes and plasma for the regulation of hemostasis in type II diabetics].
Sinzinger H; Fitscha P
Vasa; 1985; 14(2):121-4. PubMed ID: 4013489
[No Abstract] [Full Text] [Related]
15. Cholesterol, platelets adhesiveness and fibrinolytic activity in ischaemic heart disease.
Gupta KK
J Assoc Physicians India; 1969 May; 17(5):323-31. PubMed ID: 5350177
[No Abstract] [Full Text] [Related]
16. The effect of osmotic shock on platelet membrane transport.
Yardimci TU
Haematologica; 1980 Aug; 65(4):516-22. PubMed ID: 6774925
[No Abstract] [Full Text] [Related]
17. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
[TBL] [Abstract][Full Text] [Related]
18. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of atherosclerosis and blood platelets: problems of platelet activation in arteriosclerosis--with special reference to platelet membrane receptors].
Satoh Y; Tanaka Y; Satoh H
Nihon Rinsho; 1988 Mar; 46(3):582-9. PubMed ID: 2841513
[No Abstract] [Full Text] [Related]
20. Role of platelets in atherosclerosis.
Sinzinger H
Semin Thromb Hemost; 1986 Apr; 12(2):124-33. PubMed ID: 3738529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
